APA (7th ed.) Citation

Zhao, Z., Jiang, X., Wen, S., & Hao, Y. Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: A multicenter propensity score matching analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhao, Zhonghua, Xiongying Jiang, Shiping Wen, and Yanzhang Hao. Efficiency and Safety of HAIC Combined with Lenvatinib and Tislelizumab for Advanced Hepatocellular Carcinoma with High Tumor Burden: A Multicenter Propensity Score Matching Analysis. Frontiers Media S.A.

MLA (9th ed.) Citation

Zhao, Zhonghua, et al. Efficiency and Safety of HAIC Combined with Lenvatinib and Tislelizumab for Advanced Hepatocellular Carcinoma with High Tumor Burden: A Multicenter Propensity Score Matching Analysis. Frontiers Media S.A.